Stock Rich List
Nasdaq: NBIX

Neurocrine Biosciences insiders

The officers, directors and 10% owners of Neurocrine Biosciences, Inc. who hold the most stock, valued at the live NBIX price.

$156.59
NBIX today −$6.3M (−3.85%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
13
Their NBIX stock
$182M
Market value
$15.85B
Held by ranked insiders
1.15%

Insiders by value of NBIX holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Kevin Charles GormanDirector517,797$81.1M0.51%1758th
2Kyle GanoChief Executive Officer155,010$24.3M0.15%4475th
3Gary A. LyonsDirector122,141$19.1M0.12%4752nd
4Eric BenevichChief Commercial Officer67,297$10.5M<0.1%8450th
5Darin LippoldtChief Legal Officer56,793$8.9M<0.1%9599th
6Eiry RobertsChief Medical Officer51,331$8.0M<0.1%9979th
7William H. RastetterDirector43,678$6.8M<0.1%8559th
8Matt AbernethyChief Financial Officer42,808$6.7M<0.1%11766th
9Malcolm Lloyd-SmithChief Integration Officer42,337$6.6M<0.1%11860th
10Richard F. PopsDirector37,798$5.9M<0.1%1997th
11Stephen A. SherwinDirector14,860$2.3M<0.1%12656th
12Johanna MercierDirector6,853$1.1M<0.1%5303rd
13Christine A. PoonDirector4,753$744K<0.1%7643rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Neurocrine Biosciences; see each profile for the filing.